Meningococcal disease caused by serogroup B Neisseria meningitidis remains an important health problem in many parts of the world, and there are currently no comprehensive vaccines. Poor immunogenicity, combined with immunological identity to human sialic acids, have hindered the development of a serogroup B conjugate vaccine, resulting in the development of alternative vaccine candidates, including many outer-membrane protein (OMP)-based formulations. However, the design of protein-based meningococcal vaccines is complicated by the high level of genetic and antigenic diversity of the meningococcus. Knowledge of the extent and structuring of this diversity can have implications for the use of particular proteins as potential vaccine candidates. With this in mind, the diversity of the meningococcal OMP HmbR was investigated among N. meningitidis isolates representative of major hyper-invasive lineages. In common with other meningococcal antigens, the genetic diversity of hmbR resulted from a combination of intraspecies horizontal genetic exchange and de novo mutation. Furthermore, genealogical analysis showed an association of hmbR genes with clonal complexes and the occurrence of two hmbR families, A and B. Three variable regions (VR1–VR3), located in loops 2, 3 and 4, were observed with clonal complex structuring of VR types. A minority of codons (3.9 %), located within putative surface-exposed loop regions of a 2D model, were under diversifying selection, indicating regions of the protein likely to be subject to immune attack.
BashM. C.,
LesiakK. B.,
BanksS. D.,
FraschC. E.1995; Analysis of Neisseria meningitidis class 3 outer membrane protein gene variable regions and type identification using genetic techniques. Infect Immun 63:1484–1490
BjuneG.,
HøibyE. A.,
GronnesbyJ. K.,
ArnesenO.,
FredriksenJ. H.,
HalstensenA.,
HoltenE.,
LindbakA. K.,
NøklebyH.other authors1991; Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093–1096
BlackJ. R.,
DyerD. W.,
ThompsonM. K.,
SparlingP. F.1986; Human immune response to iron-repressible outer membrane proteins of Neisseria meningitidis. Infect Immun 54:710–713
BrackenC. S.,
BaerM. T.,
Abdur-RashidA.,
HelmsW.,
StojiljkovicI.1999; Use of heme–protein complexes by the Yersinia enterocolitica HemR receptor: histidine residues are essential for receptor function. J Bacteriol 181:6063–6072
BuchananS. K.,
SmithB. S.,
VenkatramaniL.,
XiaD.,
EsserL.,
PalnitkarM.,
ChakrabortyR.,
van der HelmD.,
DeisenhoferJ.1999; Crystal structure of the outer membrane active transporter FepA from Escherichia coli. Nat Struct Biol 6:56–63
FergusonA. D.,
HofmannE.,
CoultonJ. W.,
DiederichsK.,
WelteW.1998; Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science 282:2215–2220
FergusonA. D.,
ChakrabortyR.,
SmithB. S.,
EsserL.,
van der HelmD.,
DeisenhoferJ.2002; Structural basis of gating by the outer membrane transporter FecA. Science 295:1715–1719
FinneJ.,
LeinonenM.,
MakelaP. H.1983; Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2:355–357
FraschC. E.,
TsaiC. M.,
MoccaL. F.1986; Outer membrane proteins of Neisseria meningitidis: structure and importance in meningococcal disease. Clin Invest Med 9:101–107
GuptaS.,
MaidenM. C.,
FeaversI. M.,
NeeS.,
MayR. M.,
AndersonR. M.1996; The maintenance of strain structure in populations of recombining infectious agents. Nat Med 2:437–442
HarrisonO. B.,
EvansN. J.,
BlairJ. M.,
GrimesH. S.,
TinsleyC. R.,
NassifX.,
KrizP.,
UreR.,
GrayS. J.other authors2009; Epidemiological evidence for the role of the hemoglobin receptor, HmbR, in Meningococcal virulence. J Infect Dis 200:94–98
Izadi-PruneyreN.,
HucheF.,
Lukat-RodgersG. S.,
LecroiseyA.,
GilliR.,
RodgersK. R.,
WandersmanC.,
DelepelaireP.2006; The heme transfer from the soluble HasA hemophore to its membrane-bound receptor HasR is driven by protein–protein interaction from a high to a lower affinity binding site. J Biol Chem 281:25541–25550
JacobssonS.,
MollingP.,
OlcenP.2009; Seroprevalence of antibodies against fHbp and NadA, two potential vaccine antigens for Neisseria meningitidis. Vaccine 27:5755–5759
KriegS.,
HucheF.,
DiederichsK.,
Izadi-PruneyreN.,
LecroiseyA.,
WandersmanC.,
DelepelaireP.,
WelteW.2009; Heme uptake across the outer membrane as revealed by crystal structures of the receptor–hemophore complex. Proc Natl Acad Sci U S A 106:1045–1050
LewisL. A.,
GrayE.,
WangY. P.,
RoeB. A.,
DyerD. W.1997; Molecular characterization of hpuAB, the haemoglobin–haptoglobin-utilization operon of Neisseria meningitidis. Mol Microbiol 23:737–749
LewisL. A.,
GipsonM.,
HartmanK.,
OwnbeyT.,
VaughnJ.,
DyerD. W.1999; Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of Neisseria meningitidis DNM2. Mol Microbiol 32:977–989
MadicoG.,
WelschJ. A.,
LewisL. A.,
McNaughtonA.,
PerlmanD. H.,
CostelloC. E.,
NgampasutadolJ.,
VogelU.,
GranoffD. M.,
RamS.2006; The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177:501–510
MaidenM. C.,
BygravesJ. A.,
FeilE.,
MorelliG.,
RussellJ. E.,
UrwinR.,
ZhangQ.,
ZhouJ.,
ZurthK.other authors1998; Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95:3140–3145
McGuinnessB. T.,
LambdenP. R.,
HeckelsJ. E.1993; Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol Microbiol 7:505–514
NielsenR.,
YangZ.1998; Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929–936
Perkins-BaldingD.,
BaerM. T.,
StojiljkovicI.2003; Identification of functionally important regions of a haemoglobin receptor from Neisseria meningitidis. Microbiology 149:3423–3435
RokbiB.,
MignonM.,
Maitre-WilmotteG.,
LissoloL.,
DanveB.,
CaugantD. A.,
Quentin-MilletM. J.1997; Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains. Infect Immun 65:55–63
SacchiC. T.,
LemosA. P.,
WhitneyA. M.,
SolariC. A.,
BrandtM. E.,
MellesC. E.,
FraschC. E.,
MayerL. W.1998; Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system. Clin Diagn Lab Immunol 5:348–354
SchmidtH. A.,
StrimmerK.,
VingronM.,
von HaeselerA.2002; tree-puzzle: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 18:502–504
SierraG. V.,
CampaH. C.,
VarcacelN. M.,
GarciaI. L.,
IzquierdoP. L.,
SotolongoP. F.,
CasanuevaG. V.,
RicoC. O.,
RodriguezC. R.,
TerryM. H.1991; Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann 14:195–207 discussion 208–110
StojiljkovicI.,
HwaV.,
de Saint MartinL.,
O'GaoraP.,
NassifX.,
HeffronF.,
SoM.1995; The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence. Mol Microbiol 15:531–541
SukerJ.,
FeaversI. M.,
AchtmanM.,
MorelliG.,
WangJ. F.,
MaidenM. C.1994; The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol Microbiol 12:253–265
SuzukiY.,
NeiM.2004; False-positive selection identified by ML-based methods: examples from the Sig1 gene of the diatom Thalassiosira weissflogii and the tax gene of a human T-cell lymphotropic virus. Mol Biol Evol 21:914–921
TapperoJ. W.,
LagosR.,
BallesterosA. M.,
PlikaytisB.,
WilliamsD.,
DykesJ.,
GheeslingL. L.,
CarloneG. M.,
HøibyE. A.other authors1999; Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA 281:1520–1527
ThompsonJ. D.,
HigginsD. G.,
GibsonT. J.1994; clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680
UrwinR.,
RussellJ. E.,
ThompsonE. A.,
HolmesE. C.,
FeaversI. M.,
MaidenM. C.2004; Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun 72:5955–5962
WedegeE.,
HøibyE. A.,
RosenqvistE.,
BjuneG.1998; Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun 66:3223–3231
WongW. S.,
YangZ.,
GoldmanN.,
NielsenR.2004; Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites. Genetics 168:1041–1051
ZapataG. A.,
VannW. F.,
RubinsteinY.,
FraschC. E.1992; Identification of variable region differences in Neisseria meningitidis class 3 protein sequences among five group B serotypes. Mol Microbiol 6:3493–3499